Charlottesville, VA · Founded 2020 · Privately Held (backing)
Developer of a therapeutic platform intended to offer immunotherapeutics to resist autoimmune and inflammatory diseases. Slate Bio is based in Charlottesville, VA and was founded in 2020. It was valued at $11.3 million at its seed round in May 2023, the last priced event on record. It has raised $6 million across 2 recorded rounds; the latest was a $2.8 million seed round in Dec 2022.
PMV mark · valuation
$11.3M
Oct 2026
Priced at
its seed round
May 2023
Total raised
$6.0M
Last round
Seed Round
Dec 2022
Team — not yet on record
No current team members for Slate Bio are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Slate Bio with a free account
·Watch Slate Bio: the Monday email on marks, rounds and moves
